GTC Biotherapeutics (fka GTCB)

[atchoum]

Tell me about the upside...

With 100+million shares outstanding, it's going to take a hell of a long time before this company moves up based on valuation (rather than speculation). I can see they have an interesting science story but I don't see the "investment story". Sorry.

Given the immense dilution management just effected, I think they don't see the investment story either.

So how/when is GTCB gonna earn their first 200 million in revenues? Because I think it will take that to move this stock above 2$.